Studies at the morphological and molecular level have found that transgenic (Tg) mice that overexpress myotrophin in the heart develop hypertrophy at the early age of 4 weeks; this condition worsens to heart failure (HF) at approximately 36 weeks. However, how the sustained effects of alteration in cytoarchitecture of the contractile machinery lead to malfunction of the normal heart remains unclear. Our data have shown that at 4 weeks, the cytoarchitecture observed in left ventricular (LV) tissue samples of Tg mice is similar to that of wild-type (WT) mice. However, as the disease progresses, cardiomyocytes show deterioration in some mitochondrial as well as myofibril features, evidenced by swelling of mitochondria, misalignment of myofibril structure, and blurring as well as breakage of Z-lines. At 36 weeks of age, Tg mice (the group in transition from hypertrophy to HF) show significant degenerative changes in cardiomyocytes, including swelling of mitochondria, disruption of the nuclear membrane, and absence of myofibril structure. Besides these, formation of myelin bodies was also observed, a feature typically found in human hearts with HF. Changes in Z-line architecture were further confirmed by alteration in the gene expression profile of desmin and tubulin, the two main cytoskeletal proteins. We thus conclude that Tg mice overexpressing myotrophin show no visible changes in the initiation phase (4 weeks); however, as the disease progresses, alterations in the cytoskeleton are found during the transition phase from hypertrophy to HF (36 weeks onward). Our data suggest that treatment for prevention/reversal of hypertrophy should start at the early stage of hypertrophy to prevent its transition to HF.
Heart failure (HF), the final common outcome of most primary cardiovascular diseases, is one of the most frequent causes of death worldwide. 1 The potential causes of HF are diverse but often related to hypertrophy of cardiomyocytes and fibrosis. 2, 3 Among many such possible causes, left ventricular (LV) hypertrophy is a significant risk factor for cardiovascular diseases and HF. 4 Several factors might contribute to the increased susceptibility of hypertrophied myocardium, and among them, structural abnormalities may have significant deleterious effects. However, whether the injury is reversible and the cells ultimately recover or whether membrane disruptions occur, resulting in irreversible injury and death of the cell, depends on the intensity of these factors. 5 In human hearts, the structural basis of the progression from well-compensated hypertrophy to HF is still largely unknown, and the correlation between morphological alterations and molecular changes during the different phases of the transition to HF has not yet been fully described. 6 Studies from ultrastructural changes in patients with endstage dilated cardiomyopathy (DCM) have shown an increase in fibrosis, degeneration of hypertrophied myocardial cells, and alterations of the cytoskeleton. 7 End-stage human HF is characterized by fibrosis as well as impairment of myocyte degeneration, [7] [8] [9] apoptotic cell death, 9 and HF markers such as myeloid structures. [10] [11] [12] In recent years, many cardiomyopathies have been linked to mutations in either sarcomeric or cytoskeletal proteins, resulting in cardiovascular diseases, and several mouse models have been generated to study the structural and functional changes and elucidate the pathophysiology of the disease. In the cardiac hypertrophic mouse model involving Smad4, electron microscopic observations revealed abnormal mitochondria and disruption of Z-lines. 13 Transgenic (Tg) mice with cardiac-restricted overexpression of tumor necrosis factor showed loss of sarcomeric registration and myofibril disarray as the animals aged.
However, a comprehensive chronological study of structural correlates of HF-starting from the initiation of disease, during its progression, and continuing through the transition from hypertrophy to HF-is still wanting. In addition, a still unanswered question is whether molecular changes initiate the process of cardiac hypertrophy at an early stage and drive the myocardium to abnormal cytoarchitecture leading to HF, or the reverse. Moreover, as the heart is a complex organ and HF due to hypertrophy is a dynamic and intricate process, it is important to determine at which stage the changes in cytoarchitecture start to occur. It is also important to know whether changes in cytoarchitecture that contribute to HF arise from a particular area of the myocardium and then extend/spread to other parts as the severity increases or not.
We generated a Tg mouse model overexpressing myotrophin. 15 At a young age, these mice develop cardiac hypertrophy that eventually leads to HF (approximately 36 weeks of age). Using this model, we documented the alteration of gene clusters that participate during the identification of hypertrophy and during the transition from hypertrophy to HF. Our Tg mouse model of hypertrophy is unique, because the disease course in these mice closely parallels that of human end-stage HF in both molecular (gene expression of hypertrophy marker genes, proto-oncogenes, cytokines, and growth factors) and physiological parameters (pleural effusion and lethargy). This model thus provides us the opportunity to study disease progression in vivo to dissect out the role of myotrophin-induced signaling pathways from the initiation of hypertrophy through its progression to HF. The uniqueness of this Tg model is that the structural remodeling of the myocardium as an effect of myotrophin-induced hypertrophy throughout the entire disease process can be studied in a sequential manner. This type of study is not possible with human heart samples. It is noteworthy that cardiac hypertrophy as a consequence of myotrophin overexpression has been found in this model as early as at 4 weeks of age and persists thereafter, resulting finally in HF at 36 weeks. Besides molecular changes, light-microscopic studies have also revealed some significant structural changes at the HF stage, results that indeed corroborate the idea that the myocardium also undergoes structural remodeling at the cellular level.
Cytoskeletal changes in myocytes have been documented during cardiac hypertrophy. 16 An enhanced polymerization of tubulin and microtubule formation has been shown to correlate with an increase in cytoskeletal stiffness. Therefore, as a marker for cytoskeletal changes, we have quantified the changes in tubulin and desmin (both at the mRNA and protein level) during progression of cardiac hypertrophy to HF in the Tg mouse model.
The purposes of this study are to define (1) the mode of cytoarchitectural alteration at initiation to progression and transition of hypertrophy to HF and (2) the changes in cytoskeleton in parallel to ultrastructural changes during progression of hypertrophy to HF.
MATERIALS AND METHODS Experimental Design
Animal model used To study the ultrastructural changes during the progression of cardiac hypertrophy in the LV, we have selected three different age groups of the Tg mouse model, generated in our laboratory, which develops hypertrophy early and progresses to HF as a result of overexpression of myotrophin in the heart. The Tg groups were compared with age-matched wildtype (WT) mice.
Generation of Tg mice
An a-MHC-myotrophin transgene was constructed using a recombinant myotrophin (myo) in a pcDNA3 myo-vector, as described previously. 15 Pronuclear injection was performed at the University of Cincinnati's transgenic facility, using standard techniques. This study was conducted with Tg mice from line 15.
All experiments performed were approved by the institutional animal care and use committee, according to internal policies and guidelines of the National Institutes of Health for the humane care and use of animals in research.
Experimental groups
Tg and WT animals (n ¼ 18) were divided into three different groups based on the stage of the disease: initiation (group I), consisting of 4-to 6-week-old animals; progression (group II), consisting of 16-to 24-week-old animals; and transition from hypertrophy to HF (group III), consisting of animals of age 34-36 weeks. Three Tg animals from each group were studied, each along with their WT counterparts.
Parameters chosen
This study was focused on alteration in cardiomyocytes with particular reference to the sub-cellular organelles (mitochondria and nucleus) and also myofibril structure in general.
Sampling procedure and imaging
To have a random, unbiased, and global view of the samples studied, the experimental design was set up as follows. From each animal's LV (myocardial wall), three longitudinal pieces were taken from the front (subepicardial), middle (mid wall), and back (subendocardial) portions, each of which were then subdivided into a top and a bottom block. Many small pieces of tissue were prepared from each of these blocks, and finally one sample was selected at random for embedding.
The direction of sectioning was longitudinal for each case. At least 15 ultrathin sections were cut from each of the blocks and placed on copper grids.
Finally, one grid was randomly selected and each of the grids was studied under the electron microscope at four corners and at the center. Thus, for each heart (LV), a total of 30 possible locations were used for evaluation (Figure 1 ).
The micrographs taken from each zone were analyzed on a computer using the software Image Pro Plus (Version 6.0; Media Cybernetics, Bethesda, MD, USA) and Capture (Version 6.0).
Morphometry/semiquantitative scoring
To evaluate the degree of ultrastructural damage, a semiquantitative scoring system was used for cardiomyocytes focusing on subcellular structures such as mitochondria, nucleus, and myofibril arrangement (Table 1) . Test fields were selected at a primary magnification of 3000 Â by systematic uniform random sampling. Areas of ultrastructural damage were assessed according to a four-point scale for all of these parameters. 5 The EM pictures were read by blinded readers, who were not aware of the groups or genotypes of the mice.
Tissue processing for electron microscopy Both WT and Tg mice were euthanized by carbon dioxide, then 0.1 ml 10% potassium chloride was injected to the LV to stop the heart at diastole. The hearts were removed, washed in phosphate-buffered saline (PBS), and kept in cardioplegic solution 17 for 1 min, followed by incubation in 2.5% glutaraldehyde and 4% formaldehyde (4 1C overnight). The LVs were then separated and cut into pieces. The pieces were post fixed in 1% osmium tetraoxide and embedded using an Epon 812 kit. Ultrathin (85 nm) sections were cut and stained with uranyl acetate and lead citrate and examined under a Philips CM12 transmission electron microscope at a voltage of 60 kV.
Data collection and statistical analysis
All data collected from the WT and Tg animals of different groups were coded, recorded, and analyzed. Mann-Whitney statistical analyses were used for comparing differences among groups. Data were expressed as the mean value ± s.e.m., and Po0.05 was accepted as statistically significant. Statistical analyses showed that the values obtained from different zones were not significantly different, and the changes were homogeneously distributed throughout the tissue samples. Therefore, only mean values from all the samples were considered.
For the three groups (initiation, progression, and transition), total counts were as shown: mitochondria, 3600 (WT, 1 800; Tg, 1 800); nuclei, 110 (WT, 54; Tg, 56); and myofibrils, 587 (WT, 310; Tg, 277).
Distribution per Zone of the Changed Organelles
To assess whether there was any 'zone-wise' bias in the intensity of damage, each heart sample was critically examined. Ultrastructural changes in heart failure A Gupta et al
LVs of the heart samples from transition-phase animals of each type (WT and Tg) were divided into six parts, which were randomly chosen to assure a global representation. The data counted from each test field were critically analyzed.
Western Blot Analysis
Hearts of 4-, 16-, and 36-week-old WT and Tg mice were aseptically taken out and washed with cold PBS to remove the blood. Hearts were then minced with a sterile blade and lysed on ice in a buffer containing 10 mM Tris-Cl (pH 7.5), 150 mM sodium chloride, 5 mM magnesium chloride, 1 mM ethylenediaminetetraacetic acid, 10 mM sodium pyrophosphate, 10% glycerol, 50 mM sodium fluoride, 100 M sodium orthovanadate, 10 nM okadaic acid, 0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1% Triton-X-100, 1 mg/ ml leupeptin, 10 mg/ml aprotinin, and 1 mg/ml pepstatin. The lysates were centrifuged at 14 000 Â g for 20 min at 4 1C. The total protein concentration was measured by the Bradford method. Samples containing 50 mg of protein were separated on 10% sodium dodecyl sulfate-polyacrylamide gels and were electrophoretically transferred onto polyvinylidene fluoride membrane using a wet transfer apparatus (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were incubated in a blocking buffer containing 5% nonfat dry milk (Bio-Rad) in Tris-buffered saline with 0.1% Tween-20. Membranes were probed with desmin and tubulin antibodies (Sigma), overnight at 4 1C (all at 1:1000 dilution), washed three times in Tris-buffered saline with 0.1% Tween-20 and then detected using a horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescence (NEN Life Sciences, Boston, MA, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal protein loading control.
RNA Extraction and Semiquantitative RT-PCR
Hearts from WT and Tg mice of 4, 16, and 36 weeks of age were aseptically taken out and washed with cold PBS to remove the blood. Hearts were then minced with a sterile blade and total RNA was isolated from the heart of WT and Tg mice according to the protocol of Chomczynski and Sacchi. 18 RNA was re-suspended in diethylpyrocarbonate water and quantitated by optical density at 260 nm. The total RNA was treated with DNase I to remove genomic DNA contamination. By running an aliquot of the RNA sample on a denaturing agarose gel, we assessed the quality of the RNA. The first-strand cDNA reaction was performed with M-MLV (Moloney murine leukemia virus) reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and oligo-dT primers from 1 mg of total RNA. PCR amplification was performed with the same amount of the first-strand cDNA using Taq The PCR product sizes for desmin and tubulin were 475 bp and 435 bp, respectively. The amplified products were loaded and separated on 1% agarose gel and stained with ethidium bromide.
RESULTS

Changes in Mitochondria
Initiation phase (group I: 4-6 weeks of age) No structural abnormalities were observed in Tg mice at the initiation phase (group I) when compared with WT mice. The mitochondria are well preserved, possessing dense matrices filled with homogeneous matrix granules, intact double membrane, and tightly packed cristae (Figure 2a and b) .
Progression phase (group II: 16-24 weeks of age) WT animals in the progression phase (group II) also showed no conformational change in mitochondria (Figure 2c) . In Tg animals, however, a variety of changes were observed, depending on the severity of damage. The most obvious alterations were loss of matrix granules and the appearance of electron-lucent areas (Po0.05; Figure 2d ). Mitochondrial swelling (Po0.05) has also started to occur (Figure 2e ).
Transition phase from hypertrophy to HF (group III: 34 weeks onward) The transition-phase WT mice revealed more or less normal features (Figure 2f) , with a few exceptions. It is important to note that, before 36 weeks, no alteration in mitochondrial ultrastructure was ever observed in WT animals, but not significant when compared with results from the preceding age group. In Tg animals of group III, loss of matrix granules, which started earlier in the younger/previous group, showed a significant (Po0.05) increase in the transition phase (Figure 2g ). Mitochondria were more swollen (P ¼ 0.002; Figure 2h ). Changes, such as the appearance of concentric cristae, were found to be significant in the Tg animals of group III (P ¼ 0.0005; Figure 2i ).
Changes in Nucleus
Initiation phase (group I: 4-6 weeks of age) Nuclear morphology did not differ much from normal features in both WT and Tg mice at the initiation phase. All nuclei were more or less round to elliptical with a homogeneous chromatin network, intact nucleoli, and thin, continuous basal lamina (Figure 3a and b) .
Progression phase (group II: 16-24 weeks of age) Nuclei from WT mice in the progression phase did not show any significant changes (Figure 3c ). In Tg animals of group III, the most prevalent alteration was deformation in shape of the nucleus. Nuclei sometimes appeared somewhat elongated, crescent shaped, and often bizarre (Po0.001; Figure 3d ). Sometimes the nuclear membranes were found convoluted (Figure 3e ). Some myocytes of transgenic tissue showed ruptured nuclei along with rupture of nucleoli (data not shown); however, the number of occurrences was not significant.
Transition phase from hypertrophy to HF (group III: 36 weeks onward) Tissue of WT mice in the transition phase revealed no divergence from normal nuclear contour (Figure 3f) . In Tg mice, considerable structural alterations were quite evident at the onset of the transition phase. Distortion of nuclear shape was persistent in this group (Figure 3g) and severity of the disease was manifested as more convolution of nuclear membrane (Figure 3h ; Po0.0002). Among the Tg animals of group III, rupture of nuclear membrane and karyolysis were even more frequently observed (Figure 3i ; Po0.0001) when compared with their WT counterparts and mice in group II.
Changes in Myofibril Structure/Z-Line Initiation phase (group I: 4-6 weeks of age) The changes occurring in myofibril and Z-line structure reflect the contractile properties of the heart. In general, both WT ( Figure 4a ) and Tg mice (Figure 4b ) in the initiation phase (group I) showed normal ultrastructural features of Ultrastructural changes in heart failure A Gupta et al myocardial cells. They had parallel arrays of myofibrils to the longitudinal cell axis with the mitochondria. A-and I-bands, and Z-lines in the I-bands, were clearly observed.
Progression phase (group II: 16-24 weeks of age) WT animals showed no disruption in the composition or alignment of myofibril structures (Figure 4c ). In the Tg animals, the parallel and linear arrangement of the Z-lines was found to be lost with progression of the disease, and the Z-lines appeared somewhat wavy in nature (Figure 4d ), although the distance between two consecutive Z-lines was maintained. In some of the samples from Tg mice, ultrastructural analysis showed signs of sarcolysis. We could not detect any Z-lines (Figure 4e ).
Transition phase from hypertrophy to HF (group III: 36 weeks onward)
In the transition phase, WT animals showed no significant distortion in structural organization of myofibrils ( Figure  4f) . In Tg animals, the wavy Z-lines were more prominent 
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A Gupta et al along with a failure to maintain distance between two consecutive lines (Figure 4g ). In the most severe cases, we observed partial blurring and breakage of Z-lines (Po0.0001; Figure 4h ). As far as myofibril arrangement is concerned, in some cases, myocytes of the Tg animals with HF showed total disruption of the contractile system, and areas were found in which no myofibrils were observed (Figure 4i ; Po0.0001).
Besides their ultrastructural changes, accumulation of typical myelin bodies in the mitochondrial populations was discernable only in the group III Tg mice. In severely affected areas of the LV, different shapes of myelin bodies were found ( Figure 5 ). To monitor the relative transcriptional regulation of desmin and tubulin, we performed RT-PCR using the primer designed based on the GenBank sequences of mouse desmin and tubulin. The representative picture showed the profile for both desmin (475 bp) and tubulin (435 bp) at 4, 16, and 36 weeks of age with their age-matched WT counterparts. Our data showed that upregulation of tubulin starts at 16weeks of age in Tg mice when compared with their WT counterparts Ultrastructural changes in heart failure A Gupta et al (3.1-and 3.2-fold, respectively, Po0.001) but not in 4-weekold Tg mice. Similarly, we observed an upregulation of desmin starting at 4 weeks of age (1.7-fold, Po0.001) and remained elevated by 35 weeks (2.2-fold and 2.4-fold, respectively, Po0.001). We observed an upregulation of desmin and tubulin starting at 16 weeks of age in Tg mice but not in WT mice, and levels remained elevated in the Tg mice to 36 weeks of age ( Figure 6 ).
To further relate their protein expression profile during progression of cardiac hypertrophy, we performed immunoblot analysis using specific antibodies. The results are summarized in Figure 7 .
Our data showed that in Myo-Tg mice of all ages tested, cardiac desmin levels were significantly higher (2.4-, 2.8-, and 3.7-fold, respectively, Po0.001) than in the corresponding age-matched WT. Similarly, we found slight enhancement of tubulin expression level in Myo-Tg (1.29-, 1.32-, and 1.52-fold, respectively, n ¼ 3, Po0.001) compared with agematched WT.
DISCUSSION
The purpose of this study was to delineate the cytoarchitectural correlates of cardiac failure starting from initiation and progression through transition from hypertrophy to HF in a Tg mouse model overexpressing myotrophin. A careful analysis of electron microscopic studies showed that several types of subcellular alterations occurred in the LV of Tg mice when compared with their WT counterparts, with the advent of disease that reached extremity at the HF state. Tg animals of younger age did not show any detectable/significant changes in the cellular architecture, in spite of the fact that the process of hypertrophy has already begun, as evidenced by the molecular data on the same animal.
The experimental design for this study renders a random, unbiased, blinded representative sampling. Data show that there are significant and consistent changes in the Tg animals as the disease progresses. However, some changes were also observed among old WT mice, as noted below.
Mitochondrial Changes
Our data show that cardiac hypertrophy is associated with several types of changes in mitochondria, a vital organelle in the myocyte structure. However, no change was observed in the ultrastructure at the initiation phase, which may indicate that at that point the heart is not yet under a stressful condition of high oxygen demand. Loss of mitochondrial granules was among the early subcellular changes observed in Tg mice in the progression phase (group II; Po0.05). The native mitochondrial granules are known to disappear not only in the setting of hypoxia, but also in states of high oxygen stress. 19 This finding explains the increasing oxygen demand of the cells in the present model as the disease progresses.
Another ultrastructural feature that was particularly prominent in this study was the swelling of mitochondria, which started as early as the progression phase (group II) in Tg mice. The Tg mice in HF showed the greatest number of swollen Figure 5 Electron photomicrograph of 'Myelin body' (arrow) in LV myocytes of Tg animal at transition from hypertrophy to heart failure (bar ¼ 1 mm). Figure 6 RT-PCR analysis of desmin and tubulin. Total RNA was extracted from WT and Tg mice hearts at 4, 16, and 36 weeks of age. Semiquantitative PCR was performed using first-strand cDNA from each of the WT and Tg hearts using their gene-specific primers as described in the Materials and Methods section. GAPDH was used as an internal RNA loading control. Results are presented in three separate experiments (Po0.001 compared with corresponding WT counterparts). Figure 7 Western blot analysis of desmin and tubulin. Total cardiac lysate was prepared from WT and Tg mice hearts at 4, 16, and 36 weeks of age. Western blotting was performed using their specific antibodies described in the Materials and Methods section. Results are presented in three separate experiments (Po0.001 compared with WT mice).
mitochondria. Interestingly, age-matched WT animals also showed some swollen mitochondria among the normal mitochondrial population, which was significant when compared with mice in the progression phase (Po0.05). Studies have shown that mitochondria appear swollen when adenosine-5 0 -triphosphate (ATP) content is lost, and openings appear suddenly of translucent spaces between cristae, leading to a decrease in oxidative phosphorylation. 20 Hence, it is noteworthy that higher energy demand is a natural consequence of the aging process, which is manifested prematurely in Tg animals as an effect of hypertrophic disease. Some researchers have shown a relationship between ATP, lactate changes, and mitochondrial swelling. If the changes were marked, the swelling was marked as well. Conversely, a lesser degree of change was associated with less swelling. 4 However, as the disease progressed, the earlier change that was noted stopped progressing, and no further deterioration in mitochondria was observed among the HF group (group III) animals ( Figure 8 ). The ratio of normal to swollen mitochondria rose with increasing severity of disease (Figure 8 ). Ultrastructural changes in heart failure A Gupta et al
Nuclear Changes
Changes to the cell nucleus were also found to be fairly consistent in our study. Hypertrophic cardiomyocytes with mild-to-moderate degeneration showed deviations from the normal shape and an increase in convolutions of the nuclear membrane. It has been postulated that during ventricular hypertrophy, the length of the nucleus increases whereas its diameter remains normal. In addition, there is increased synthesis of nuclear membrane to accommodate the increased volume, which leads to increases in folding, convolutions, and deformation in shape. 21 The appearance of convolutions in the nuclear membrane of Tg mice in the progression phase, as observed in our study, corroborates this idea.
The elongated and bizarre shapes observed in the nuclei of Tg mice (mild in progression-phase and severe in transitionphase animals) suggest that longitudinal and radial forces generated by ventricular chamber dilation may further exacerbate the effects of physical stress as the disease advances. Although the consequences of altered shape and size are yet to be defined, adverse effects on nuclear organization and function are likely. Structural changes in nuclear envelopes have been observed in cardiomyocytes in which the lamin A/C gene is abnormal. 22 In addition, the occurrence of altered nuclear morphology suggests that there may be defects in nuclear pore transport and/or transcription regulation. 23 In this study, altered nuclear shape, size, and intranuclear organization, as well as dilation of the nuclear envelope shape (convolution), might cause or accompany changes in nuclear pore structure that would critically influence nuclear cytoplasmic transport and, hence, a range of nuclear functions.
Myofibril Structural Changes
Sarcomeric disorganization and Z-line abnormalities were found in myocytes from Tg mice, starting from the progression phase in this study. It is interesting to note that not all the sections from an individual mouse showed this misalignment. This discrepancy may have been because of a greater degree of variability in the local conditions under which the tissues are taken. However, as hypertrophic disease progresses, the misalignment becomes severe in Tg animals in the transition phase, no matter from which site the tissue was collected. Breakage and blurring of Z-lines may result from the non-uniform stretching of the myocytes, which are found to be present in the transition phase. The severity of tissue injury reaches its maximum level in Tg animals in the transition phase and is manifested by a total loss of myofibrils. Compensating for this loss of myofibrils, there is an increase in unspecified cytoplasm, fibrotic material, and interstitial collagen fiber. 24 This other matter may be responsible for the stiffness of the ventricular wall observed at the end stage of dilated cardiomyopathy.
The Z-disc is involved in sarcomeric organization, force generation, and transmission and exerts an effect as an interface between contractile proteins, other cytoskeletal elements, and signaling molecules.
Desmin, the major intermediate filament in the sarcomere, is thought to be a major stress-bearing element there. It forms a ring-like band around myofibrils at the Z-line level with longitudinal bands running parallel to the myofibrils in the interfibrillar space and connecting mitochondria and desmosomes at the cardiac intercalated discs. 25 In our Myo-Tg model, we observed an upregulation of desmin at both the transcriptional and translational level in compensated hypertrophy and further increased in decompensated hypertrophied hearts.
Tubulin exists as polymer-forming microtubules (a major component of the cytoskeleton in the myocyte) and has been found to increase in human and animal models of cardiac hypertrophy and HF. Enhanced tubulin polymerization and microtubule formation have been found to correlate with a concomitant increase in cytoskeletal stiffness. 26, 27 It is possible that the functional abnormalities associated with the cardiac hypertrophy in these Tg mice may be related to the hyperpolymerization of structural proteins such as tubulin and desmin. Specifically, densification of the microtubule and intermediate filament networks of the myocyte would likely impose a greater load on the myocyte and exert an effect to reduce the compliance of the cell and impede sarcomere motion and force production. Thus, increased tubulin and desmin protein levels in Myo-Tg mice may represent an important inciting mechanism for HF.
The most unique feature observed in this study is the random and homogeneous occurrence of myelin bodies, at different phases of formation, in the Tg mice in the transition phase. Myelin figures are indicative of mitochondrial damage 10 when found in human HF samples, but it was not very clear at which point in time they occur during the progression of disease. Our extensive study in the hypertrophic murine model, starting from initiation and progression through transition from hypertrophy to HF, documented that these structures start to appear only at the end stage, and also, the formation of myelin body is a sequential phenomenon rather than a sudden mitochondrial alteration. However, an in-depth study on the formation of the said structure has yet to be conducted.
A zone-wise distribution of the altered organelles representing the severity of damage to the cardiomyocytes was critically scrutinized for the first time during the study, in which we used a thorough, random sampling method. It appears that there is no zone-wise bias with regard to the severity of damage, and it is more likely that the damage we found is homogeneous in distribution.
Our current study has shown that the complicated and comprehensive process of transition from hypertrophy to HF is associated with abnormal cardiac ultrastructure in the LV of Tg mice that overexpress myotrophin. The changes involve three main cell components, namely, mitochondria, nucleus, and myofibril structure. In conclusion, the effects of cardiac hypertrophy are observed at the molecular and biochemical as well as functional level, before there is any sign of structural abnormalities. Our findings also suggest that alterations in the cytoarchitecture of cardiomyocytes may contribute to further deterioration in the functioning of heart, but only at the point when the disease has already started; it appears that these structural anomalies are less likely to be involved in bringing about the initiation process of the disease. However, the extent of injury to the cells amplifies as the disease advances, reaching extremity at the transition phase from hypertrophy to HF. Hence, we conclude that the subcellular structural changes observed in this study serve to further promote the deterioration, already initiated by some other factors, possibly molecular changes. Moreover, the sampling procedures we used rendered a uniform, homogeneous, and representative study of the samples, which clearly indicates that the subcellular changes observed in this study are global and not focal.
